Abirapro 250 mg Tablet

Product Details

Abirapro 250 mg Tablet contains abiraterone acetate, a medication specifically used in the management of prostate cancer. It reduces the production of androgens, hormones that can fuel the growth of prostate cancer cells.

Uses

• Metastatic Castration-Resistant Prostate Cancer (mCRPC): Abirapro is commonly used alongside prednisone to treat advanced prostate cancer that no longer responds to traditional hormonal therapy.
• Metastatic High-Risk Castration-Sensitive Prostate Cancer (mHSPC): Often administered in combination with androgen deprivation therapy (ADT).

How Abirapro Works

Abiraterone inhibits CYP17, an enzyme necessary for the production of androgens. By reducing androgen levels, it helps to limit the growth and spread of prostate cancer cells.

Common Side Effects

• Increased blood pressure (hypertension)
• Fatigue and weakness
• Joint and muscle pain
• Low blood potassium (hypokalemia)
• Fluid retention (edema)

Serious Side Effects (Seek Medical Attention)

• Severe liver toxicity
• Adrenal insufficiency
• Heart problems, such as irregular heartbeat
• Severe allergic reactions

Key Features

• Contains abiraterone acetate, a targeted therapy for prostate cancer.
• Blocks androgen production, slowing disease progression.
• Effective as part of combination therapies in advanced prostate cancer cases.

Frequently Asked Questions (FAQ)

1. How should I take Abirapro 250 mg Tablet?
   Take the tablet as prescribed by your healthcare provider, typically on an empty stomach (1 hour before or 2 hours after meals).
2. Is Abirapro suitable for women?
   No, it is not intended for use in women and is contraindicated during pregnancy due to potential harm to the fetus.
3. Can Abirapro interact with other medications?
   Yes, discuss any other medications or supplements with your doctor to prevent interactions.

References

1. FDA – Abiraterone Information
   Available from: https://www.drugs.com/abiraterone.html
   Accessed on: November 11, 2024.
2. National Comprehensive Cancer Network (NCCN)
   Available from: https://en.wikipedia.org/wiki/Abiraterone_acetate